S. Branford, Z. Rudzki, S. Walsh, et al. Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and muta-tions in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis. Blood, 2003, 102: 276-283.